Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

LAO Guo-qin, TANG Zhi-hua, WANG Jia-liang. Cost-effectiveness analysis of 4 therapeutic schemes for chronic hepatitis B[J]. Journal of Pharmaceutical Practice and Service, 2004, (6): 374-376.
Citation: LAO Guo-qin, TANG Zhi-hua, WANG Jia-liang. Cost-effectiveness analysis of 4 therapeutic schemes for chronic hepatitis B[J]. Journal of Pharmaceutical Practice and Service, 2004, (6): 374-376.

Cost-effectiveness analysis of 4 therapeutic schemes for chronic hepatitis B

  • Received Date: 2004-06-15
  • Objective To evaluate the economic effectiveness of different drug therapeutic schemes for the same disease.Methods Using pharmacoeconomical cost-effectiveness analysis,four therapeutic schemes for chronic hepatitis B (A-alkoloids sophora injection, B-lamivudine + thymosin, C-interferon, D-lamivudine) were compared.Results The effective rates of four groups were 74.14%, 91.25%,82.86% and 83.33% respectively; The adverse drug reaction rates were 12.07%,8.75%,38.57% and 1.39%.And the cos-effectiveness ratios were respectively 88.83,134.89,174.11 and 91.03.Conclusion Schemes D are the best one.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(1808) PDF downloads(322) Cited by()

Related
Proportional views

Cost-effectiveness analysis of 4 therapeutic schemes for chronic hepatitis B

Abstract: Objective To evaluate the economic effectiveness of different drug therapeutic schemes for the same disease.Methods Using pharmacoeconomical cost-effectiveness analysis,four therapeutic schemes for chronic hepatitis B (A-alkoloids sophora injection, B-lamivudine + thymosin, C-interferon, D-lamivudine) were compared.Results The effective rates of four groups were 74.14%, 91.25%,82.86% and 83.33% respectively; The adverse drug reaction rates were 12.07%,8.75%,38.57% and 1.39%.And the cos-effectiveness ratios were respectively 88.83,134.89,174.11 and 91.03.Conclusion Schemes D are the best one.

LAO Guo-qin, TANG Zhi-hua, WANG Jia-liang. Cost-effectiveness analysis of 4 therapeutic schemes for chronic hepatitis B[J]. Journal of Pharmaceutical Practice and Service, 2004, (6): 374-376.
Citation: LAO Guo-qin, TANG Zhi-hua, WANG Jia-liang. Cost-effectiveness analysis of 4 therapeutic schemes for chronic hepatitis B[J]. Journal of Pharmaceutical Practice and Service, 2004, (6): 374-376.

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return